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Polarized epithelia develop distinct cell surface domains, with the apical 1	
membrane acquiring characteristic morphological features such as microvilli. 2	
Cell polarization is driven by polarity determinants including the evolutionarily 3	
conserved partitioning defective (PAR) proteins that are separated into distinct 4	
cortical domains. PAR protein segregation is thought to be a consequence of 5	
asymmetric actomyosin contractions. The mechanism of activation of apically 6	
polarized actomyosin contractility is unknown. Here we show that the Cdc42 7	
effector MRCK activates Myosin-II at the apical pole to segregate aPKC-Par6 8	
from junctional Par3, defining the apical domain. Apically polarized MRCK-9	
activated actomyosin contractility is reinforced by cooperation with aPKC-Par6 10	
downregulating antagonistic RhoA-driven junctional actomyosin contractility, 11	
and drives polarization of cytosolic brush border determinants and apical 12	
morphogenesis. MRCK-activated polarized actomyosin contractility is required 13	
for apical differentiation and morphogenesis in vertebrate epithelia and 14	
Drosophila photoreceptors. Our results identify an apical origin of actomyosin-15	
driven morphogenesis that couples cytoskeletal reorganization to PAR polarity 16	
signalling. 17	
 18	
Epithelial cells polarize and form distinct cell surface domains that have different 19	
biochemical compositions, reflecting their different functions1. The apical domain often 20	
undergoes a morphogenetic process leading to the development of actin-rich structures that 21	
support specific apical functions, such as the brush border membrane of absorptive epithelia 22	
or the light-harvesting domain of Drosophila photoreceptors. Formation of such apical 23	
specializations relies on the recruitment of specific cytosolic factors that determine apical 24	
morphogenesis and, hence, requires asymmetric distribution of cytosolic components2. 25	
Epithelial polarization is regulated by apical and basolateral polarity determinants3. Among 26	
which are the evolutionarily conserved PAR proteins that segregate into two distinct cortical 27	
domains4, 5. In epithelia, the boundary between the two domains, the apical/lateral border 28	
(tight junctions in vertebrates, adherens junctions in flies), is marked by Par3, which is 29	
recruited to the cell surface bound to the Par6-aPKC complex. In response to apical Cdc42 30	
activation, Par3 dissociates, demarking the apical/lateral border, and the Par6-aPKC complex 31	
segregates into the differentiating apical domain6, 7. Studies in C. elegans one-cell stage 32	
embryos suggest that PAR protein segregation relies on asymmetric actomyosin activity, 33	
generating movement of anterior PAR complexes to the anterior pole, which results in the 34	
formation of two cortical domains that harbour distinct PAR proteins8-13. Anterior PAR 35	
proteins correspond to apical PARs in epithelia. The functional importance of actomyosin 36	
and, if relevant, how and where asymmetric Myosin-II activity is generated to drive apical 37	
accumulation of PAR proteins in epithelia is not clear. Identifying such mechanisms, 38	
however, is essential to understand how the interplay between mechanical forces generated 39	
by actomyosin contractility and biochemical signalling guide epithelial polarization and 40	
morphogenesis. 41	
 In epithelia, RhoA is known to generate contractile forces driving junction formation and 42	
remodelling, a mechanism important during apical constriction and developmental processes 43	
requiring epithelial sheet movement and elongation14-16. In contrast, apical Cdc42 activation 44	
not only drives apical differentiation but also promotes apical expansion at the cost of the 45	
basolateral domain, counteracting junctional actomyosin-generated apical constriction17. In 46	
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analogy to the C. elegans embryo model, one would expect a mechanism of Myosin-II 1	
activation at the apical pole to create an actomyosin activity gradient that favours apical 2	
polarization if apical segregation of Par6-aPKC is indeed driven by actomyosin contractions. 3	
Therefore, we asked if and how apical Cdc42 signalling activates asymmetric actomyosin 4	
contractility to stimulate apical polarization and plasma membrane morphogenesis, and how 5	
such a mechanism interacts with counteracting junctional RhoA signalling. Here, we show 6	
that the Cdc42 effector MRCK activates apical actomyosin contractility, initiating a pathway 7	
regulating apical morphogenesis, and cooperates with the aPKC-Par6 complex, which 8	
downregulates RhoA-driven junctional actomyosin contractility, to drive apical polarization. 9	
 10	
RESULTS 11	
MRCK-activated Myosin-II drives apical morphogenesis 12	
 As epithelial cells polarize and develop a specialized apical membrane domain, Myosin-II 13	
polarizes apically at distinct sites along the apical membrane domain including the junctional 14	
circumferential actomyosin belt18, 19. In cultured canine kidney epithelial MDCK cells that 15	
spontaneously differentiate, we found that phosphorylated MLC (myosin regulatory light 16	
chain), demarking active Myosin-II, is localised basolaterally in non-polarized cells and 17	
becomes increasingly enriched along the apical membrane domain, forming ‘caps’ that define 18	
the apical cellular cortex, as epithelial cells polarize and differentiate over a period of a few 19	
days (Fig.1a). Since apical polarization of PAR proteins and morphogenesis depends on 20	
apically polarized Cdc42 activation3, 20, we asked whether a Cdc42-dependent mechanism 21	
driving polarized Myosin-II activation is at the origin of apical polarization and 22	
morphogenesis.  23	
 MRCKs are Cdc42 effector kinases that activate Myosin-II by phosphorylating MLC21. 24	
Using spontaneously differentiating MDCK cells, we asked whether siRNA-mediated MRCK 25	
knockdown affected formation of apical actomyosin caps. Indeed, MRCK depleted cells 26	
failed to form differentiated apical membranes as microvilli did not assemble, apical 27	
accumulation of F-actin and active Myosin-II did not occur, and had a reduced cell height 28	
(Fig. 1b-h, Supplementary Fig. 1a-c).  All of these MRCK siRNA-induced effects were 29	
rescued by expression of siRNA resistant MRCKb-flag, supporting specificity. MRCK was 30	
also required for the differentiation of human intestinal epithelial Caco-2 cells that also 31	
spontaneously polarize and differentiate (Supplementary Fig. 1c,d). Hence, MRCK is 32	
essential for the differentiation of vertebrate epithelial cells from different tissues. 33	
 To determine whether MRCK-generated apical Myosin-II activation is a conserved 34	
mechanism, we turned to D. melanogaster: their differentiating photoreceptors represent a 35	
well-characterized invertebrate model system to study epithelial polarity, PAR polarity 36	
signalling, and apical differentiation5, 7, 22-24. Drosophila photoreceptors undergo epithelial 37	
polarity remodelling during retinal development and evolve a characteristic, F-actin-rich 38	
apical membrane domain (Fig. 2a).  Strikingly, differentiating photoreceptors displayed 39	
active Myosin caps at the apical cortex, which were not formed in cells mutant for 40	
gek/MRCK25 (Fig. 2b). Loss of gek function also resulted in attenuation of F-actin signal at 41	
the apical membrane domain and gross defects in the morphology of the F-actin rich apical 42	
organelle known as the rhabdomere (Fig. 2c-f), which consists of a stack of approximately 43	
60.000 microvilli, indicative of defective actomyosin contractility22. Introduction of a 44	
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phosphomimetic MLC transgene, spaghetti squash-EE (sqhEE), rescued the phenotype of gek 1	
mutant cells, demonstrating Myosin-II activation acts downstream of gek/MRCK (Fig. 2g,h). 2	
MRCK is thus a conserved driver of apical Myosin activation and morphogenesis in 3	
vertebrate epithelia and Drosophila photoreceptors.  4	
 5	
Apical determinant Dbl3, a Cdc42 guanine nucleotide exchange factor, controls MRCK 6	
activity 7	
 We have previously shown that the guanine nucleotide exchange factor Dbl3 activates 8	
Cdc42 at the apical pole to drive epithelial polarization and morphogenesis17. To determine 9	
whether Dbl3 signalling stimulates MRCK-mediated Myosin activation, we conditionally 10	
expressed Dbl3-myc in MDCK cells. This resulted in increased apical phosphorylation of 11	
MLC along with enhanced apical F-actin accumulation and microvilli induction; both 12	
inhibited by knockdown of MRCK (Fig. 3a-e). Inhibition of ROCKI/II in polarizing MDCK 13	
cells did not prevent apical actomyosin activation and morphogenesis, indicating that apical 14	
Myosin activation is not Rho dependent (Supplementary Fig. 2). Moreover, our results 15	
indicate that Dbl3 is a major activator of MRCK in mammalian cells since constitutive 16	
overexpression of MRCKb-Flag could not rescue Db3 knockdown effects (Supplementary 17	
Fig. 3a-d). Only catalytically active, but not inactive Dbl3 that is unable to activate Cdc4217, 18	
activated MLC phosphorylation (Fig. 3f). Thus, the activation of apical Myosin caps requires 19	
Cdc42 and MRCK activation.  20	
 To determine the temporal nature of apical MLC activation, we generated a conditional 21	
Dbl3-Myc MDCK-cell-line that constitutively expresses EGFP-MLC; the conditional Dbl3-22	
myc transgene was then induced by the addition of tetracycline. Time-lapse fluorescence 23	
microscopy revealed that concurrent to induction of Dbl3-myc protein, increased apical 24	
EGFP-MLC activity was detected from 2.5h of tetracycline treatment (Supplementary video 25	
1; Supplementary Fig. 3e). Analysis in fixed cells revealed that conditional expression of 26	
Dbl3-myc resulted in active Myosin cap formation 2.5 hours from the onset of tetracycline 27	
addition along with apical accumulation of MRCKb, increasing further at 6 hours, along the 28	
expanding apical membrane domain (Fig. 4a; Supplementary Fig. 3f,g). Thus, apical MRCK 29	
recruitment and MLC phosphorylation follow the Dbl3-myc protein expression profile. 30	
Apical actomyosin cap formation correlated with apical polarization of Par6-aPKC, the brush 31	
border component Ezrin, and microvilli induction (Fig. 4a-c, Supplementary Fig. 3g). 32	
Constitutive expression of MRCKb-flag, which is autoinhibited until bound to Cdc42-GTP, 33	
in conditional Dbl3-expressing cells accelerated the formation of apically activated Myosin 34	
caps, which became enriched with MRCKb-flag, polarization and brush border induction 35	
(Fig. 4b,c; Supplementary Fig. 3f,g). MRCK is thus recruited to the apical membrane by 36	
Dbl3-mediated Cdc42 activation to drive apical polarization and differentiation of epithelial 37	
cells. Apical localization of MRCKb was also observed in vivo in mouse renal tubules and 38	
intestine (Fig. 4d), and Gek was found at the apical photoreceptor cortex (Fig. 4e). Hence, 39	
apical MRCK polarization occurs in vitro and in vivo, and in vertebrates and invertebrates.   40	
 41	
 42	
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Apical Cdc42 activates a dual effector mechanism that antagonises junctional Myosin 1	
activity 2	
 RhoA and ROCK regulate actomyosin activity along cell-cell junctions, generating a 3	
circumferential actomyosin belt that is required for junction assembly and remodelling, and 4	
apical constriction15, 18, 19. Activation of apical Cdc42 by Dbl3 promotes apical expansion17, a 5	
process opposing apical constriction. Apical Cdc42 signalling may thus not only promote 6	
apical MRCK-driven Myosin activation but also downregulate junctional actomyosin 7	
contractility to create an actomyosin activity gradient that favours apical expansion and apical 8	
PAR protein segregation. In agreement with apical activation of Myosin-II by MRCK, 9	
conditional expression of Dbl3-myc stimulated apical Cdc42 activity, as revealed by a FRET 10	
biosensor, confirming previously published loss of function experiments (Fig. 5a,b)17. 11	
Addition of a Cdc42 inhibitor during Dbl3 induction26, blocked the formation of apical active 12	
Myosin caps (Fig. 5c,d). Cdc42 activation is thus required for Dbl3 to induce MRCK-13	
dependent, apically polarized actomyosin caps. Dbl3 stimulates apical Cdc42-dependent 14	
aPKC-PAR6 effector complex activation and, hence, enrichment of aPKC at the cell cortex 15	
(Fig. 5e,f; Supplementary Fig. 4a)17. As aPKC is an inhibitor of the RhoA activator LULU-16	
216, we asked whether Cdc42 activates a dual effector mechanism that downregulates 17	
junctional Myosin-II activity via aPKC whilst activating apical actomyosin contractility via 18	
MRCK (Fig. 5g).  19	
 To determine whether Dbl3-induced Cdc42 activation is indeed an inhibitor of RhoA at 20	
junctions, we first monitored junctional localization of LULU-2 and p114RhoGEF.  The 21	
latter protein is a major junctional guanine nucleotide exchange factor for RhoA that is 22	
activated by binding to LULU-2, a FERM (4.1 protein, ezrin, radixin, moesin) domain-23	
containing protein homologous to Drosophila Yurt15, 16, 27. Concomitant with increased 24	
aPKCz recruitment, conditional expression of Dbl3-myc promoted LULU-2 dissociation 25	
from junctions (Fig. 6a,b; Supplementary Fig. 4d). Junctional p114RhoGEF levels also 26	
decreased upon Dbl3 induction (Fig. 6a,b; Supplementary Fig. 4d). Dbl3 induction did not 27	
affect expression levels of LULU-2 and p114RhoGEF but resulted in enhanced Ezrin 28	
phosphorylation, a marker of apical differentiation (Supplementary Fig. 4b,c). Dbl3-myc 29	
induction thus leads to reduced junctional association of proteins that activate RhoA 30	
signalling. To confirm that junctional recruitment of LULU-2 is regulated by Dbl3 activated 31	
aPKC, we knocked down Dbl3 or inhibited aPKCz activity, which resulted in an increase in 32	
LULU-2 localization at cell junctions (Supplementary Fig. 4e-h). These results indicate that 33	
apical activation of Cdc42 antagonizes the molecular machinery that activates RhoA at cell 34	
junctions.  35	
 We next asked if RhoA activity and junctional actomyosin activation is indeed affected by 36	
Dbl3 signalling. Analysis of RhoA activity at the apical domain using a FRET biosensor 37	
revealed enriched RhoA activity at cell-cell contacts as previously reported15. Induction of 38	
Dbl3 expression resulted in a 50% decrease in RhoA activity at cell-cell contacts (Fig. 6c,d). 39	
Similarly, a GFP fusion protein containing the RhoA binding domain of rhotekin, another 40	
sensor to monitor the cellular distribution of active RhoA28, was enriched at cell-cell contacts 41	
prior to Dbl3 induction but diffusely distributed when expression of the exchange factor had 42	
been induced, supporting the conclusion that enhanced Dbl3 signalling inhibits junctional 43	
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RhoA activity (Fig. 6e).  Active p114RhoGEF forms a stable complex with ROCKII and 1	
Myosin-II, stimulating junctional double phosphorylation of MLC (ppMLC)15. Conditional 2	
expression of Dbl3 strongly reduced junctional ppMLC staining (Fig. 6f,g), further 3	
supporting an inactivation of the p114RhoGEF/RhoA pathway that promotes junctional 4	
Myosin-II activation. Thus, Dbl3 activates apical Cdc42 and thereby stimulates two effector 5	
mechanisms: induction of apical MLC phosphorylation by MRCK and aPKC-stimulated 6	
downregulation of junctional RhoA-dependent actomyosin contractility. Dbl3 signalling 7	
hence leads to a shift in the actomyosin activity gradient to stimulate apical polarization (Fig. 8	
6h). These results further indicate distinct roles for RhoA-ROCK and Cdc42-MRCK 9	
signalling in epithelia.  Indeed, loss of the RhoA effector ROCK using the null allele rok2 did 10	
not affect apical Myosin-II activation in developing pupal Drosophila photoreceptors (Fig. 11	
6i), which is MRCK dependent (Fig. 2b). In contrast, adherens junction remodelling in eye 12	
imaginal discs, a rok-dependent process requiring junctional actomyosin activity29, was not 13	
affected in cells mutant for gek/MRCK (Fig. 6k). MRCK and ROCK thus regulate distinct 14	
morphogenetic processes. 15	
 16	
MRCK-activated Myosin-II motor activity promotes PAR protein dissociation and 17	
separation  18	
 Cortical polarization of PAR proteins is thought to rely on both biochemical signals and 19	
mechanical forces generated by actomyosin contractions6-13. Cdc42 activation promotes 20	
apical polarization by stimulating activation of Par6-aPKC, leading to recruitment to 21	
junctions, Par3 phosphorylation and biochemical destabilisation of the initial Par6-22	
aPKC/Par3 complex6, 7. Since activation of apical actomyosin contractility by MRCK 23	
stimulates apical differentiation, we asked whether MRCK-activated Myosin-II mediates 24	
aPKC-Par6 separation from Par3 at junctions. To determine first whether MRCK activity 25	
itself is required, we used an inhibitor that blocks the catalytic activity of MRCK30. Induction 26	
of Dbl3-myc expression led to shift of the position of tight junctions, demarked by Par3, from 27	
the apical end of the lateral membrane towards the basal membrane, and an extended apical 28	
domain, labelled by aPKC, and a reduced basolateral domain, stained with anti-scribble 29	
antibody, as previously described (Fig. 7a)17. Inhibition of MRCK blocked separation of Par3 30	
from aPKC as well as the junctional shift in control and Dbl3 overexpressing cells, indicating 31	
that MRCK activity was required even when apical Cdc42 activation and, hence, aPKC 32	
signalling17 was increased by enhanced expression of the guanine nucleotide exchange factor. 33	
If the same experiments were repeated with blebbistatin, an inhibitor of Myosin-II motor 34	
activity that blocks actomyosin contractions31, separation of aPKC from Par3 and junctional 35	
shifting was also inhibited, and led to increased stable complex assembly (Fig. 7b,c). 36	
Blebbistatin also strongly attenuated brush border induction (Fig. 7d,e) comparable to what 37	
we had observed in response to depletion of MRCK (Fig. 3a). Thus, these results indicate that 38	
MRCK-activated Myosin-II motor activity is required for separation of Par6-aPKC from Par3 39	
upon apical Cdc42 activation but not for the initial recruitment of Par6-aPKC to form the 40	
tight junction-associated complex with Par3. This is in agreement with the reported diffusive 41	
properties of PAR proteins in	C. elegans, where PAR protein segregation, but not cortical 42	
recruitment, is actomyosin-dependent32. Since Dbl3-mediated Cdc42 activation also 43	
stimulates aPKC to phosphorylate Par317 and to down-regulate junctional RhoA signalling 44	
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(Fig. 6), our results demonstrate that both effector mechanisms stimulated by active apical 1	
Cdc42 are required for apical PAR protein separation and segregation: The biochemical 2	
activity of aPKC-Par6 that destabilizes the PAR complex and downregulates junctional 3	
Myosin contractility, and the activation of apical Myosin contractility by MRCK that drives 4	
apical PAR protein separation and domain morphogenesis. 5	
 6	
Dbl3/MRCK-stimulated actomyosin contractility drives apical segregation of PAR 7	
proteins and polarization of cytosolic brush border determinants 8	
     Cdc42-activated aPKC-Par6 recruitment to junctions is a transient process and the 9	
complex then proceeds to expand along the apical membrane, segregating from Par3 and tight 10	
junctions, to define the apical cortex33. Hence, we next asked whether expansion along the 11	
apical membrane is powered by MRCK-dependent and Myosin-II motor activity. Polarization 12	
of aPKC-Par6 along the apical cell cortex, which formed a stable complex, was inhibited in 13	
conditional Dbl3-myc expressing cells treated with blebbistatin and rapidly reversed 14	
following wash-out (Fig. 8a,b; Supplementary Fig. 5). The reversal of Myosin motor 15	
inhibition required MRCK kinase activity, confirming the requirement of MRCK-dependent 16	
Myosin-II activation for apical polarization of the aPKC-Par6 complex (Fig. 8c,d). It is 17	
thought that a rapid apical phosphorylation/dephosphorylation cycle of Ezrin is required to 18	
confine Ezrin and microvilli to the apical membrane domain in polarized epithelial cells, 19	
which is facilitated by apical localization of cytosolic factors such as the kinase SLK34,35. 20	
Similarly, NHERF-1/EBP-50 engages in a transient association with Ezrin to regulate 21	
microvillar structure34. Myosin motor-dependant cortical polarization was concomitant with 22	
an apical enrichment of such cytosolic regulators of brush border formation and was required 23	
for their co-localization with Ezrin at the apical pole, indicating that MRCK-induced apical 24	
domain formation included polarization of cytosolic factors required for plasma membrane 25	
specialization and morphogenesis (Fig. 8e-i and Supplementary Fig. 6). Our data thus support 26	
a model in which epithelial cortical polarization and cytosolic polarization are linked32. 27	
Hence, MRCK signalling unifies the mechanisms for asymmetric segregation of cytosolic 28	
components to the vicinity of the apical membrane with cortical polarization (Fig. 8j). Apical 29	
membrane staining of aPKC and Moesin in Drosophila gek mutant photoreceptors was also 30	
attenuated (Fig. 8k,l; Supplementary Fig. 7). These effects were rescued by co-expression of 31	
sqhEE, a phosphomimetic MLC construct, in mutant gek/MRCK cells (Fig. 8m,n), 32	
demonstrating the importance of gek/MRCK activation of Myosin-II for apical differentiation 33	
of Drosophila photoreceptors.  34	
 35	
DISCUSSION 36	
 We have identified a distinct, evolutionarily conserved actomyosin-powered 37	
morphogenetic pathway at the apical domain that is activated by Cdc42/MRCK and drives 38	
epithelial morphogenesis and the development of epithelial polarity. Cdc42/MRCK signalling 39	
serves to coordinate biochemical signalling and actomyosin-generated mechanical forces. 40	
Unlike the mechanism of action of Cdc42, the spatial activation of Cdc42 is likely to vary 41	
across species since far less GEF diversity exists in Drosophila, and the closest orthologue of 42	
Dbl3 in insects lacks a Sec14 domain, which is crucial for Dbl3 function in vertebrates17.  43	
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 Cell polarization is thought to be induced by mechanical forces generated by an 1	
actomyosin activity gradient11-13, 32. Our results indicate that apical Cdc42/MRCK signalling 2	
functions in the culminating stages of epithelial polarization leading to the accumulation of 3	
Par6 and aPKC at the apical domain by promoting the actomyosin-driven segregation of the 4	
Par6-aPKC complex from the junctional complex along the differentiating apical domain and 5	
thus promoting apical identity and morphogenesis. Moreover, cytosolic factors that regulate 6	
apical membrane specialization such as SLK and NHERF-1/EBP-50, which mediate localised 7	
Ezrin activation and brush border assembly, are concentrated at the apical pole, linking 8	
cortical and cytosolic polarization. As active Ezrin also promotes apical Dbl3 recruitment and 9	
Cdc42 activation17, this process represents a positive feedback mechanism that enhances 10	
apical differentiation and reinforces the polarized epithelial phenotype.  11	
 Apical Cdc42 activation stimulates two cooperating effector pathways that induce the 12	
formation of apically polarized actomyosin contractility to drive PAR protein polarization: 13	
MRCK-mediated apical Myosin-II activation and Par6-aPKC-mediated inhibition of 14	
junctional RhoA activation via negative regulation of LULU-2 and p114RhoGEF and, hence, 15	
reduced junctional actomyosin contractility. The biochemical activity of aPKC-Par6 also 16	
supports apical PAR segregation by phosphorylating Par3 and, thereby, destabilising its 17	
interaction with the aPKC-Par6 complex6, 7, 17. Hence, activation of the two Cdc42 effector 18	
pathways integrates biochemical and mechanical force-generating pathways stimulating 19	
apical segregation of PAR proteins, polarization and domain morphogenesis. The 20	
downregulation of junctional RhoA signalling by apical Cdc42 activation further suggests a 21	
sequential model for the function of ROCK and MRCK in Myosin-II activation: 22	
RhoA/ROCK signalling drives early steps of junction formation15 and remodelling such as in 23	
the early eye disc29, 36, 37, subsequent Cdc42/MRCK activation then leads to a reorientation of 24	
the actomyosin contractility gradient and, hence, apical polarization and differentiation. The 25	
antagonism between junctional RhoA and apical Cdc42 signalling may be bidirectional. In 26	
vertebrates, junctional RhoA activity is generated by p114RhoGEF, a pathway that is 27	
stimulated in cells that undergo apical constriction due to increased levels of LULU-215, 16. 28	
The fly homologue of LULU-2, Yurt, regulates apical domain size negatively by inhibiting 29	
the activity of Crumbs, which is positively regulated by aPKC27, suggesting that LULU-30	
2/Yurt signalling may indeed antagonize apical Cdc42-driven mechanisms. Hence, 31	
mechanisms of mutual antagonism between Cdc42/MRCK and RhoA/ROCK driven 32	
actomyosin contractility may exist that create a cellular code for dynamic polarized 33	
morphogenetic processes underlying the generation of tissue- and organ-specific cell surface 34	
fates during differentiation of various cell types. 35	
 36	
METHODS 37	
Methods, including statements of data availability and references, are available in the online 38	
version of this paper. 39	
 40	
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Figure 1: MRCK activates apical actomyosin contractility that controls apical 2	
morphogenesis. (a) Spontaneous polarization of MDCK cells leads to the formation of apical 3	
actomyosin caps positive for p-MLC and F-actin. (b) Expression of MRCKb as analysed by 4	
immunoblotting of total cell extracts. (c,d) Scanning electron microscopy of apical domains 5	
reveals levels of microvilli induction by MDCK cells upon depletion of MRCK without or 6	
with complementation with exogenously expressed MRCKb-flag. (e,f) Measurement of 7	
active Myosin at cortical caps (A) and basal membrane (B) during polarization and 8	
differentiation of cells depleted of or rescued for MRCK expression by confocal 9	
immunofluorescence microscopy. (g,h) Measured cell height and F-actin levels in polarizing 10	
cells with or without MRCK function. For all quantifications, n=3 independent experiments 11	
and shown are the data points, means ± 1 SD (in black), the total number of cells analysed for 12	
each type of sample across all experiments, and p-values derived from t-tests. Arrowheads 13	
point to the apical cortex demarked by F-actin. Unprocessed original scans of blots are shown 14	
in Supplementary Figure 8. Scale bars: electron micrographs, 1µm; confocal 15	
immunofluorescence images, 10µm.  16	
 17	
	 13 
Figure 2: 1	
MRCK/gek regulates apical Myosin activation and morphogenesis in differentiating 2	
Drosophila photoreceptors. (a) Scheme illustrating the similarities and corresponding 3	
plasma membrane domains of vertebrate epithelial cells and Drosophila photoreceptors. 4	
Indicated are apical microvilli and the apical zone enriched in active Myosin-II. (b-d) 5	
Confocal sections of Drosophila pupal mosaic retinas showing wild type cells (blue nuclei) 6	
and cells mutant for gek were stained for F-actin (c) or p-MLC (b). Mutant cells are labelled 7	
with asterisks. Quantification of apical actin enrichment shows analysis of wild type and 8	
mutant cells (paired within sections; n represents 11 animals, a t-test was used to calculate the 9	
p value). (e,f) Analysis of rhabdomere integrity in wild type and gek mutant cells using 2 10	
different gek alleles (gekNP5192 or gek1080) demonstrates severe defects including splitting. 11	
(g,h) Confocal sections of Drosophila eyes showing wild type cells and cells mutant for 12	
gekNP5192 but expressing sqh-SqhEE (blue nuclei; labelled with asterisks; the quantification 13	
represents pairs within sections and is based on n = 8 animals, a t-test was used to calculate 14	
the p value).   15	
	 14 
 1	
Figure 3: MRCK functions as an effector of Dbl3-Cdc42 signalling.  (a) Scanning 2	
electron microscopy analysis of microvilli induction by MDCK cells with tetracycline-3	
inducible Dbl3-myc expression transfected with MRCK siRNA determined by measuring 4	
areas of microvilli clusters from SEM scans.  (b-d) Induction of active Myosin at cortical 5	
caps (A) or basal membrane (B), and enrichment of F-actin at the apical cortex during 6	
polarization and differentiation, stimulated by conditional expression of Dbl3-myc with or 7	
without MRCK siRNA knockdown. White arrowheads highlight the apical membrane cortex 8	
labelled for F-actin. (e) Immunoblot analysis of total active Myosin levels following 9	
conditional expression of Dbl3-myc and siRNA knockdown of MRCK. (f) Immunoblot 10	
analysis of total active Myosin-II levels following conditional expression of Dbl3-myc or 11	
GEF inactive Dbl3Y645A-myc. The schematic illustrates the formation of apical caps formed 12	
by activated Myosin-II and F-actin. Unprocessed original scans of blots are shown in 13	
Supplementary Figure 8. For all quantifications, n=3 independent experiments and shown are 14	
the data points, means ± 1 SD (in black), the total number of cells analysed for each type of 15	
sample across all experiments, and p-values derived from t-tests. Scale bars: a, 1µm; b, 16	
10µm.  17	
	 15 
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Figure 4:  Cdc42 activates MRCK apically, stimulating apical Myosin-II activation and 2	
differentiation. (a-c) Analysis and quantification of apical pMLC, aPKCz and pEzrinT567 at 3	
the apical membrane domain using confocal z-section analysis and of brush border induction 4	
using scanning electron microscopy of MDCK cells with tetracycline-inducible Dbl3-myc 5	
expression with or without constitutive expression of MRCKb-flag. White arrowheads 6	
highlight the apical membrane cortex labelled for F-actin. (d) Localization of MRCKb in 7	
mouse kidney and small intestine. (e) Localization of Gek in polarizing pupal Drosophila 8	
photoreceptors. For all quantifications, n=3 independent experiments and shown are the data 9	
points, means ± 1 SD, the total number of cells analysed for each type of sample across all 10	
experiments, and p-values derived from t-tests (red/blue values refer to comparisons within 11	
categories and black value to comparisons between categories after 2.5h). In panels d and e, 12	
arrows point to apical domains positive for MRCK/Gek. Scale bars: electron micrographs, 13	
1µm; confocal immunofluorescence images, 10 µm.  14	
	 16 
 1	
Figure 5: Dbl3 and Cdc42 drive apical actomyosin activation and aPKC recruitment. 2	
(a,b) FRET analysis of Cdc42 activity at the apical aspect of MDCK cells conditionally 3	
expressing Dbl3-myc. (c,d) Confocal microscopy of pMLC and F-actin at the apical 4	
membrane domain of MDCK cells conditionally expressing Dbl3-myc induced with 5	
tetracycline in the absence or presence of Cdc42 inhibitor. White arrowheads highlight the 6	
apical membrane cortex labelled for F-actin. (e,f) Analysis of aPKCz localization in MDCK 7	
cells with tetracycline-inducible Dbl3-myc expression. White arrowheads point to the lateral 8	
junctional complex. (g) Schematic diagram illustrating activation of two effector 9	
mechanisms, MRCK/Myosin-II and Par6-aPKC by Dbl3 stimulated apical Cd42-activation. 10	
Quantifications show shown are (b) box blots (25th to 75th percentiles, with a line at the 11	
median; whiskers extend to the max/min data points; n=36 cells -Tet and n=46 cells +Tet; p 12	
value was calculated with a Wilcoxon test), or (d, f) based on n=3 independent experiments 13	
and showing the data points, means ± 1 SD (in black), the total number of cells analysed for 14	
each type of sample across all experiments, and p-values derived from t-tests. Scale bars: 10 15	
µm.  16	
	 17 
 1	
Figure 6: Apical activation of Cdc42 by Dbl3 antagonizes junctional RhoA-stimulated 2	
Myosin-II activation. (a,b) Conditional tetracycline-induced expression of Dbl3 in MDCK 3	
cells stimulates loss of junctional RhoA signalling components p114RhoGEF and LULU-2. 4	
Shown are confocal xy and z-sections. Junctions are indicated by white arrowheads. (c,d) 5	
FRET analysis of RhoA activity in MDCK cells conditionally expressing Dbl3-myc (white 6	
arrowheads indicate cell-cell contacts) (e) Confocal analysis of MDCK cells transiently 7	
expressing the active RhoA binding domain of rhotekin fused to GFP (GFP-rGBD), 8	
conditionally expressing Dbl3-myc (white arrowheads indicate cell-cell junctions). (f,g) 9	
Confocal analysis of junctional pMLC activity in MDCK cells conditionally expressing 10	
Dbl3-myc. (i) Confocal sections of a Drosophila retina showing wild type cells (blue)  and 11	
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cells mutant for the RhoA effector null allele rok2 (white asterisks) that were stained for 1	
pMLC and Armadillo (Arm), the orthologue of mammalian b-catenin. White asterisks 2	
indicate rok2-mtant cells. (j) Maximum intensity projection of confocal sections of a mosaic 3	
Drosophila eye imaginal disc showing wild type cells (blue nuclei) and cells mutant for 4	
gekNP5192 and stained for Armadillo (Arm) and pMLC (MF, morphogenetic furrow; the 5	
dashed white lines indicate the borders between wild type and mutant cells; arrowheads point 6	
to Myosin-II-rich cell junctions). The schematic diagram illustrates the generation of apically 7	
polarized actomyosin activation by apical activation of MRCK and inactivation of junctional 8	
RhoA signalling by aPKC. Quantifications show shown are (d) box blots (25th to 75th 9	
percentiles, with a line at the median; whiskers extend to the max/min data points; n=35 cells 10	
-Tet and n=37 cells +Tet; p value was calculated with a Wilcoxon test), or (b, d, g) based on 11	
n=3 independent experiments and showing the data points, means ± 1 SD (in black), the total 12	
number of cells analysed for each type of sample across all experiments, and p-values derived 13	
from t-tests. Scale bars: 10 µm. 14	
  15	
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 2	
Figure 7: MRCK-stimulated Myosin-II activation drives PAR separation at tight 3	
junctions. (a,b) Confocal analysis of aPKCz localization at tights junctions in 4	
medium/advanced polarizing/differentiating MDCK cells with tetracycline-inducible Dbl3-5	
myc expression without or with (a) BDP5290, a MRCK inhibitor, or (b) blebbistatin, a 6	
Myosin-II inhibitor. The position of tight junctions, demarked by Par3, is indicated by white 7	
arrowheads. Note, tight junctions move towards the basal membrane in response to apical 8	
expansion17. The larger magnifications show examples of cells in which aPKC segregates 9	
from Par3 (all controls and enhanced by Dbl3-myc expression) or in which aPKC and Par3 10	
co-localise (cells treated with MRCK or Myosin-II inhibitor). aPKCz segregation from Par3 11	
at tight junctions is highlighted by ‘Seg’. (c) Immunoprecipitation analysis of aPKCz-Par3 12	
complex formation in cells conditionally expressing Dbl3-myc with or without blebbistatin. 13	
Note, increased Par3-aPKC complex formation in Dbl3-myc-induced cells without 14	
blebbistatin is due to increased transient interactions that promote apical expansion17. (d,e) 15	
Quantification of microvilli induction in MDCK cells conditionally expressing Dbl3-myc -/+ 16	
Myosin-II inhibition. The quantification in panel d is based on n=3 independent experiments 17	
and shown are the data points, means ± 1 SD (in black), the total number of cells analysed for 18	
each type of sample across all experiments, and p-values derived from t-tests. Unprocessed 19	
original scans of blots are shown in Supplementary Figure 8. Scale bars: electron 20	
micrographs, 1µm; confocal immunofluorescence images, 10 µm.  21	
	 20 
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Figure 8: MRCK-activated actomyosin contractility drives apical PAR segregation and 2	
polarization of cytosolic factors. (a,b) Levels of EGFP-Lifeact (EGFP-LA), Par polarity and 3	
brush border proteins localized at the apical membrane domain in MDCK cells conditionally 4	
expressing Dbl3-myc, treated with blebbistatin and followed by washout (WO). (c,d) Levels 5	
of EGFP-Lifeact (EGFP-LA) enrichment at the apical membrane domain of MDCK cells 6	
conditionally expressing Dbl3-myc following blebbistatin treatment and washout in the 7	
absence or presence of BDP5290 to inhibit catalytic activity of MRCK. (e-i) Measurements 8	
of co-localization coefficients of PAR polarity and brush border proteins at the apical 9	
membrane domain in MDCK cells conditionally expressing Dbl3-myc transiently inhibited 10	
with blebbistatin followed by wash out for 2 hours (green indicates co-localisation, see also 11	
Supplementary figures 5 and 6; arrowheads point to apical membrane). (j) Schematic model 12	
	 21 
of polarity induced by apical stimulation of Cdc42, activating a dual effector mechanism to 1	
generate asymmetric actomyosin contractions, apical PAR domain formation and membrane 2	
morphogenesis. Bright green represents co-localization of Par and brush border proteins. (k-3	
n) Quantification of confocal sections of pupal retinas stained for the apical markers aPKC 4	
and Moesin comparing wild type cells and gek mutant cells (k, l), or wild type cells and cells 5	
mutant for gek expressing SqhEE (m, n). Quantifications in panels b, d, f, h, and i are based on 6	
n=3 independent experiments and shown are the data points, means ± 1 SD (in black), the 7	
total number of cells analysed for each type of sample across all experiments, and p-values 8	
derived from t-tests. Quantifications in panels k-n of protein expression levels compare 9	
measurements from wild type and neighbouring mutant cells (paired within sections; see 10	
Supplementary Fig. 7 for representative images); k, n=10 animals; l, n=8 animals; m and n, 11	
n=7 animals; p values were calculated with t-tests). Scale bars: 10 µm.  12	
  13	
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METHODS 1	
Cell culture and generation of mammalian expression vectors and cell Lines 2	
MDCK and Caco-2 cells were grown in DMEM supplemented with 10% or 20%, 3	
respectively, foetal bovine serum (original cell stocks were obtained from Ira Mellman 4	
(MDCK cells) and Hans-Peter Hauri (Caco-2 cells)	 17, 38, 39. Fresh batches of cells from a 5	
contamination-free stock that had been tested for mycoplasma (MycoAlert; Promega Inc.) 6	
were used to replace fresh cultures every 6 to 8 weeks. Cells were then weekly stained with 7	
Hoechst dye to reveal nuclei and DNA of contaminants such as mycoplasma. MRCK 8	
inhibitor BDP5290 was synthesized by the Cancer Research UK Beatson Institute Drug 9	
Discovery Group and used at a concentration of 10µM. Blebbistatin (10µM final 10	
concentration), the Cdc42 inhibitor ML141 (10µM), and the ROCKI/II inhibitor GSK 269962 11	
(10nM) were purchased from Tocris Bioscience. The aPKCz-myristoylated inhibitor was 12	
purchased from Merck Millipore and used at a concentration of 40µM. For conditional 13	
expression of Dbl3-myc, Dbl3 pcDNATO-myc expression vector system was constructed as 14	
described in Zihni et al., 201417.  MDCK cells were transfected with a plasmid encoding the 15	
tetracycline repressor (pcDNA6-TR) using the calcium phosphate method17, cultured in 16	
DMEM with 10% foetal bovine serum and selected with Blasticidin (0.5µg/ml).  Selected 17	
clones were then transfected with pCDNA4TO-Dbl3-myc and selected in DMEM with 10% 18	
foetal bovine serum with Blasticidin (0.5µg/ml; PAA Laboratories Inc.) and Zeocin 19	
(200µg/ml; Thermo Fisher Scientific). The MDCK pcDNA4TO-Dbl3-myc/MRCKβ-flag 20	
cell-line was generated by transfecting rat MRCKb-flag into the MDCK pcDNATO-Dbl3-21	
myc	TET-R cell-line and selecting in DMEM with 10% foetal bovine serum with Blastocidin 22	
(0.5µg/ml), Zeocin (200µg/ml) and G418/Geneticin (600µg/ml; Thermo Fisher Scientific). 23	
MDCK and Caco-2 cells constitutively expressing MRCKβ-flag were transfected 24	
analogously and cultured in DMEM with either 10% or 20% foetal bovine serum and G418 25	
(600µg/ml G418). To generate EGFP-LA or EGFP-MLC pcDNA4TO-Dbl3-myc MDCK 26	
TET-R cell-lines retroviral transduction constructs EGFP-Lifeact were cloned at EcoRI and 27	
XhoI sites using the following primers:  5’ GAA TTC ATG GGT GTC GCA GAT TTG ATC 28	
AAG AAA TTC GAA AGC ATC TCA AAG GAA GAA CTC GAG 3’ and 5’ CTC GAG 29	
TTC TTC CTT TGA GAT GCT TTC GAA TTT CTT GAT CAA ATC TGC GAC ACC 30	
CAT GAA TTC 3’ and MLC by PCR amplification using the following primers  5’ CAA TAA 31	
GAA TTC ATG TCC AGC AAG CGG GCC AAA GC 3’ and 5’ GAC TTC CTC GAG CTA 32	
GTC GTC TTT ATC CTT GGC G 3’  into retroviral packing vector pMSC28 EGFP IRES 33	
Puro, a MLV-based retroviral system as described previously40. Constructs were co-34	
transfected with pVSVG into GP2-293 cells (Clontech). Supernatants were collected, 35	
clarified by centrifugation (200XG, 5 mins) filtered (0.45µm) and used to infect MDCK Dbl3 36	
Tet-R cells in the presence of 8µg/ml polybrene (Millipore) at (MOI) <1. Cell lines were 37	
selected for with either Puromycin or G418 (Thermo Fisher Scientific) at final concentration 38	
of 2.0µg/ml or 800µg/ml respectively. Selected clonal cell lines were grown on maintenance 39	
concentration of 0.5µg/ml Puromycin or 400µg/ml G418.   40	
	41	
Transfection 42	
	 23 
Cells were cultured and transfected using Interferin transfection reagent (Polyplus 1	
Transfection) using the method described in Zihni et al.17 using siRNAs targeting the 2	
following sequences: human MRCKpan  5’-CGAGAAGACTTTGAAATAA-3’; canine 3	
MRCKpan 5’-AGAGAAGACTTTGAGATAT-3’; canine Dbl3 5’-4	
AAGAUAUCGCCUUCUUGUC-3’. The MRCK siRNA sequences are not conserved in the 5	
rat mRNA, enabling rescue experiments with the rat cDNA encoding MRCKβ.  6	
 7	
Mammalian antibodies and immunological methods 8	
Fixation and processing cells and mouse tissue sections was as previously described19.  The 9	
following antibodies were used: EHM2/Lulu-2, goat polyclonal (abcam ab77484) 1/50 for 10	
immunofluorescence and 1/250 for immunoblotting16; Par3, rabbit polyclonal (Upstate, 11	
Millipore 07-330) 1/500 for immunofluorescence and 1/2000 for immunoblotting; PAR6β, 12	
rabbit polyclonal H-64 (Santa Cruz Biotechnology sc-67392) 1/200 for immunofluorescence 13	
and 1/1000 for immunoblotting;  aPKCζ, mouse monoclonal (Santa Cruz Biotechnology sc-14	
17781) 1/200 for immunofluorescence and 1/1000 for immunoblotting; occludin, mouse 15	
monoclonal (Invitrogen, ThermoFisher Scientific 33-150) 1/1000 for immunofluorescence; 16	
Scribble, goat polyclonal (Santa Cruz Biotechnology sc-11049) immunofluorescence 1/200; 17	
MRCKβ, rabbit polyclonal (Santa Cruz Biotechnology sc-48834) immunofluorescence 1/200 18	
and immunoblotting 1/500, Ezrin Mouse monoclonal 3C12 (Santa Cruz Biotechnology sc-19	
58758) immunofluorescence 1/500 and immunoblotting 1/1000; phospho- EzrinT567, rabbit 20	
polyclonal (abcam ab47293) immunofluorescence 1/500 and immunoblotting 1/2000; p-MLC 21	
S19, mouse monoclonal and pp-MLC Thr18, S19 rabbit polyclonal (Cell Signaling 22	
Technology 3675 and 3674) immunofluorescence 1/100 and 1/200,  respectively, and 23	
immunoblotting 1/1000; SLK,  goat polyclonal (Santa Cruz Biotechnology sc-79068) 24	
immunofluorescence 1/100 and immunoblotting 1/1000; NHERF1/EBP50, rabbit polyclonal 25	
(Santa Cruz Biotechnology sc-134485) immunofluorescence 1/100 and immunoblotting 26	
1/1000; p114RhoGEF, mouse monoclonal (GeneTex GTX629806) immunoblotting 1/1000; 27	
p114RhoGEF, rabbit polyclonal (GeneTex GTX102223) immunofluorescence 1/50. An 28	
affinity-purified rabbit polyclonal was used for ZO-1, immunofluorescence 1/400	41-43. 29	
Phalloidin-Atto 647 reagent was obtained from Sigma Aldrich and diluted 1/1000 (65906). 30	
Affinity-purified and cross-adsorbed Alexa488-, Cy3- and Cy5-labelled donkey anti-mouse, 31	
rabbit, and goat secondary antibodies were from Jackson ImmunoResearch Laboratories 32	
(1/300 diluted from 50% glycerol stocks).  Affinity-purified HRP-conjugated goat anti mouse 33	
and rabbit, and donkey anti goat secondary antibodies 1/5000 were also from Jackson 34	
ImmunoResearch Laboratories (1/5000 diluted from 50% glycerol stocks).  For 35	
immunofluorescence analysis cells and tissues were mounted using Prolong Gold antifade 36	
reagent (Life technologies P36930) and imaging was performed using Zeiss 700 and 710 37	
confocal microscopes and a 64x oil lens/NA1.4. Images were processed using Zeiss Zen 2009 38	
and Adobe Photoshop CS5 and 10 software.  Co-immunoprecipitation and immunoblotting 39	
was carried out using methods previously described and were repeated at least three times19. 	40	
 41	
Rho GTPase activity assays 42	
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For FRET experiments, cells were plated into ibid multi-well chamber slides and then 1	
transfected with pRaichu-RhoA or pRaichu-Cdc42 (kindly provided by M. Matsuda, Osaka  2	
University, Japan)44. The FRET analysis was performed at 37oC with a Nikon Eclipse Ti-E 3	
inverted microscope equipped with excitation and emission CFP and YFP filters in external 4	
filter wheels and using a CFI Apochromat Nano-Crystal 60x oil lens (N.A., 1.2). Crossover 5	
between CFP and YFP filters was calibrated by imaging CFP and YFP expressed alone using 6	
all four emission/excitation filter combinations. FRET efficiency maps were then produced 7	
with the Nikon software and quantified with ImageJ. The plasmid encoding the GFP-RhoA-8	
rGBD construct was obtained from addgene and was described previously28. 9	
Mammalian electron microscopy 10	
Cells were fixed and cut and mounted for scanning electron microscopy as previously 11	
described19.  Samples were analysed in a Sigma Field Emission scanning electron microscope 12	
(Carl Zeiss) operating at 5kV.  Digital images were recorded using Carl Zeiss (SmartSEM) 13	
software. 14	
 15	
Drosophila strains and genetics 16	
Flies were maintained at 25°C on standard food. To generate whole mutant eyes, the 17	
EGUF/GMRhid system was used45 in combination with the gekNP5192 and gekomb1080alleles 25. 18	
Canton S flies were used as control. Mosaic gek retinas where generated using the following 19	
genotype: eyflp ; FRT42D Ubi-myrRFP / FRT42D gek.  Rescue experiments were performed 20	
using the the MARCM technique46 combined to the sqh-SqhE20,21 transgene 47. The following 21	
genotype was examined: hsFLP,Tubulin-Gal4, nuGFP/+ ;  FRT42D, TubGal80/ FRT42, 22	
gekNP5192 ; sqh-SqhE20E21/+. Pupal retinas where staged and stained according as described48.  23	
Drosophila antibodies and immunological methods 24	
Whole mount retinas were prepared as described in48.  The following antibodies were used: 25	
rabbit anti-p-MLC Ser19, 1/40 (Cell Signaling Technology 3671); rabbit anti-PKCζ 1/200 26	
(Sigma Aldrich SAB4502380), mouse anti-Arm 1/200 (N27-A1, Developmental Studies 27	
Hybridoma Bank), rabbit anti-Gek 1/25 (gift from TR Clandinin25, rabbit anti-P-Moesin 28	
1/50049, phalloidin-Texas Red (Sigma Aldrich, 300nM) with the appropriate combination of 29	
secondary antibodies conjugated to Dy405, Alexa488, Cy3 or Cy5 as appropriate at 1/200 30	
each (Jackson ImmunoResearch). Retinas were mounted in VectaShield and imaging was 31	
performed using a Leica SP5 confocal.  Images were processed using ImageJ and Adobe 32	
Photoshop 7.0.  33	
 34	
Drosophila electron microscopy  35	
Electron microscopy was performed as in50 using a Tecnai G2 Spirit transmission electron 36	
microscope (FEI, The Netherlands) equipped with a Morada CCD camera (Olympus Soft 37	
Imaging Systems).  Image quantification was performed using iTEM software. 38	
 39	
Statistics and reproducibility 40	
Mammalian epithelial cells - Microvilli induction was measured as cluster areas since 41	
clusters represent advanced microvilli induction during differentiation that proceeds initial 42	
	 25 
bud formation at the early stage of differentiation51.  Cluster areas were measured in scanning 1	
electron micrographs using Nikon Imaging software (NIS) (Supplementary Figure 1) by 2	
determining threshold intensity.  2-3 areas of each cell at a magnification of 40,000x were 3	
measured to accommodate cluster variation in each cell. Cell height was measured in Zeiss 4	
700 confocal Z-sections using Zeiss Zen2000 imaging software. Co-localisation coefficients 5	
were calculated with the Zeiss 700 microscope software. Cell height was measured using basal 6	
and apical markers and at 3µM intervals to accommodate for variation of height along 7	
individual cells, and values were then averaged.  p-MLC (ser19), F-actin, EFP-LA, polarity 8	
and brush border protein pixel intensity was measured using Image-J software.  For each cell 9	
background was measured and subtracted from the sample value.  Co-localization 10	
coefficients were measured in Zeiss Confocal XY or Z-scans using Zeiss Zen 2000 co-11	
localization software that applies the principal of the Pearson’s coefficient, using cross-hairs 12	
facility to subtract background from each channel. For the quantifications shown, the 13	
provided n values refer to independent experiments and the numbers in the graphs refer to the 14	
total of analysed cells per type of sample across all experiments. Statistical significance was 15	
tested in most experiments using two-tailed Student’s t-tests, pairing values derived from the 16	
same experiment. The FRET experiments are shown as standard box plots (25th to 75th 17	
percentiles, with a line at the median; whiskers extend to the max/min data points) and were 18	
analysed with a nonparametric Mann-Whitney-Wilcoxon test. The experiments that were not 19	
quantified in figures1b, 3e and f, and 7c, as well as supplementary figures 3e, 5b, 6e and 7c 20	
are representative for 3 experiments. Localization of MRCK in mouse tissue was analysed in 21	
sections derived from 2 different animals (figure 4d). Graphs and statistical calculations were 22	
generated using MS Excel (V15) and JMP (V12). 23	
Drosophila - Pixel intensity/membrane length measurements of apical membrane and Arm 24	
domains were determined by analysing confocal images of gek mosaic retinas at 40% APF 25	
using ImageJ. A minimum of four independent retinas were used for each genotype. 26	
Parametric samples were tested for statistical significance using paired two-tailed Student’s t-27	
test. The numbers of animals analysed: figure 2b-d, n=11; figure 2e,f, n=4 for each genotype; 28	
figure 2g,h, n=8; figure 4e, n=8; figure 6, n=4 (i); n=6 (j); figure 8, n=10 (k), n=8 (l), n=7 29	
(m), n=7 (n); and Supplementary figure 9 n=9 (a), n=7 (b), and n=7 (c,d), n=7 . 30	
 31	
Data availability 32	
All data supporting the conclusions here are available from the authors on reasonable request. 33	
 34	
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1	
Supplementary Figure 1:  Quantification of microvilli induction and role of MRCK in 2	
apical morphogenesis of Caco-2 cells. (a) Broad view of apical surface of MDCK cells by 3	
scanning electron microscopy after MRCK knockdown and after complementation with 4	
MRCKb-flag. (b) Measurement of apical membrane brush border cluster induction using 5	
threshold function of Nikon imaging software.  (c,d) Levels of microvilli induction in human 6	
Caco-2 intestinal epithelial cells following MRCK knockdown without or with 7	
complementation with MRCKb-flag. Panel d is based on n=3 independent experiments and 8	
shows the data points, means ± 1 SD (in black), the total number of cells analysed for each 9	
type of sample across all experiments, and p-values derived from t-tests.  10	
	 28 
1	
Supplementary Figure 2: Inhibition of ROCK does not affect Dbl3-induced apical 2	
actomyosin activation. Confocal analysis of apical pMLC activity and F-actin in MDCK 3	
cells upon induction of Dbl3 expression by tetracycline in a conditional cell line in the 4	
absence or presence of the ROCK inhibitor GSK269962. Arrowheads point to apical cortex. 5	
Panel b is based on n=3 independent experiments and shows the data points, means ± 1 SD 6	
(in black), the total number of cells analysed for each type of sample across all experiments, 7	
and p-values derived from t-tests. Scale bars: 10 µm. 8	
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 1	
Supplementary Figure 3:  MRCKb expression does not rescue loss of apical Myosin-II 2	
activation and differentiation in Dbl3-depleted MDCK cells: (a-c) Levels of Myosin 3	
phosphorylation at the apical membrane domain (A) and basal membrane (B) and F-actin 4	
during polarization and differentiation of MDCK cells following Dbl3 siRNA transfection 5	
and with constitutive expression of MRCKβ-flag. Quantifications are based on n=3 6	
independent experiments and show the data points, means ± 1 SD (in black), the total number 7	
of cells analysed for each type of sample across all experiments, and p-values derived from t-8	
testsshow means ± 1 SD, n+3. (d) SEM images of the effect of MRCK knock down on 9	
	 30 
microvilli induction and conditional expression of Dbl3-myc. Note, MRCKβ-flag does not 1	
rescue the Dbl3 depletion-induced phenotype. (e) Time course of tetracycline-induced Dbl3-2	
myc expression in MDCK cells.  Asterisks highlight time points with clear induction of Dbl3-3	
myc expression that were used for the functional assays. Unprocessed original scans of blots 4	
are shown in Supplementary Figure 8. (f) Confocal z-sections showing representative images 5	
of either endogenous or constitutively expressed MRCKβ in MDCK cells following 6	
conditional tetracycline-inducible expression of Dbl3-myc. Constitutive expression of 7	
MRCKβ-flag accelerates activation of Myosin-II at the apical membrane, highlighted by 8	
white arrows. Asterisks highlight basolateral MRCK localization at earlier stages of 9	
polarization. (g) Confocal Z-sections showing representative images of pEzrinT567 10	
localization in MDCK cells following conditional tetracycline-inducible expression of Dbl3-11	
myc without or with constitutive expression of MRCKb-flag.  Constitutive expression of 12	
MRCKβ-flag accelerates enrichment of active Ezrin at the apical membrane domain, 13	
indicated by white arrowheads. Scale bars: 10 µm. 14	
 15	
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 1	
Supplementary Figure 4: Cdc42 stimulates aPKC recruitment and antagonizes Rho-2	
signalling. (a) Conditional tetracycline-induced expression of Dbl3 in MDCK cells 3	
stimulates increased recruitment of aPKCz . Shown are confocal xy. (b) Levels of protein 4	
expression during tetracycline-induced Dbl3-myc expression. Unprocessed original scans of 5	
blots are shown in Supplementary Figure 8. (c) Quantification of levels of pEzrinT567D 6	
following tetracycline-induced Dbl3-myc expression. (d) Conditional tetracycline-induced 7	
expression of Dbl3 in MDCK cells stimulates loss of junctional p114RhoGEF and LULU-2. 8	
Shown are confocal z-sections. Junctions are indicated with white arrowheads. (e,f) 9	
Spontaneously polarizing MDCK cells were treated with control or Dbl3 siRNAs, or a 10	
myristoylated aPKCz inhibitor. LULU-2 localization at tight junctions was then analysed by 11	
confocal microscopy using ZO-1 as a marker for tight junctions (indicated by arrowheads). 12	
Quantifications are based on n=3 independent experiments and show the data points, means ± 13	
1 SD (in black), the total number of cells analysed for each type of sample across all 14	
experiments, and p-values derived from t-tests. Scale bars: 10 µm. 15	
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 1	
 2	
Supplementary Figure 5: MRCK-activated Myosin-II motor activity drives apical 3	
polarization of Par6-aPKC complex. (a) MDCK cells conditionally expressing tetracycline-4	
inducible Dbl3-myc were analysed by confocal microscopy using co-localization software 5	
based on the Pearson’s correlation coefficient.  Co-localization is calculated in grid 3 of the 6	
scatter charts. Bright green represents co-localization of aPKCz and Par6b, which increases 7	
and is confined to the apical cortical membrane following polarization stimulated by 8	
conditional tetracycline inducible Dbl3-myc expression in MDCK cells and is dependent on 9	
Myosin-II motor activity. Coloured outlines of apical membrane domains represent 10	
calculation areas of co-localization coefficients. Scale bars: 10µm. (b) Co-11	
immunoprecipitation of Par6 and aPKC indicating formation of stable complexes that are 12	
independent of Myosin-II motor activity and Dbl3 expression. Unprocessed original scans of 13	
blots are shown in Supplementary Figure 8. 14	
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 1	
Supplementary Figure 6: Dbl3-activated Myosin-II motor activity drives apical 2	
polarization and co-localization of brush border regulators. (a-d) MDCK cells 3	
conditionally expressing tetracycline-inducible Dbl3-myc were analysed by confocal 4	
microscopy using co-localization software based on the Pearson’s correlation coefficient. Co-5	
localization is calculated in grid 3 of the scatter charts. Bright green represents co-localization 6	
of Ezrin and SLK or NHERF-1 and SLK, which increases and is confined to the apical 7	
membrane domain following polarization stimulated by conditional tetracycline inducible 8	
Dbl3-myc expression in MDCK cells and is dependent on Myosin-II motor activity. Coloured 9	
outlines of apical membrane domains represent calculation areas of co-localization 10	
coefficients. Scale bars: 10µm. (e) Expression levels of differentiation markers upon Dbl3 11	
and Myosin manipulation. Unprocessed original scans of blots are shown in Supplementary 12	
Figure 8. 13	
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1	
Supplementary Figure 7: Myosin-II activation mediates gek function in pupal 2	
photoreceptors. (a-c) Confocal sections of a pupal retinas showing wild type cells (blue 3	
nuclei) and gek mutant cells (labelled with asterisks) stained for the apical markers aPKC and 4	
Moesin, or the junctional marker Arm. (d) Quantification of the effect of mutant gek on 5	
junctional levels of Arm (measurements from wild type and neighbouring mutant cells, 6	
paired within sections; based on n=7 animals; p value was calculated with a t-test).  7	
 8	
 9	
 10	
 11	
 12	
 13	
 14	
 15	
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Information about antibody sources
Antigen Provider Catalogue	Number Batch	Number Despription Specificity Validation
EHM2/Lulu-2 abcam ab77484 GR77589-1 goat	polyclonal Recognises	a	long	and	a	short	form	of	Lulu-2	in	human	and	canine	cells Immunoblotting	and	peptide	quenching	(http://www.abcam.com/ehm2-antibody-ab77484.html)	and	by	siRNA-mediated	depletion	(JCB	195,	245-61,	2011)
Par3 Millipore 	07-330 216672,	DAM1754440 rabbit	polyclonal Recognises	multiple	Par3	isoforms	in	human	and	canine	cells Immunoblotting	human	and	mouse	total	cell	extracts	(http://www.merckmillipore.com/GB/en/product/Anti-Partitioning-defective-3-Antibody,MM_NF-07-330?ReferrerURL=https%3A%2F%2Fwww.google.co.uk%2F&bd=1)	and	immunoprecipitation	of	MDCK	cell	extracts	and	immunofluorescence	of	MDCK	cells	(JCB	204,	111-27,	2014)
PAR6β Santa	Cruz	Biotechnology sc-67392 K2613,	A0809,		A2108 rabbit	polyclonal	H-64 Recognises	human	and	canine	PAR6β Immunoblotting,	immunoprecipitation	and	immunofluorescence	of	MDCK	and	Caco-2	cells	(JCB	204,	111-27,	2014)	and	immunoblotting	total	cell	extracts	from	different	species	(https://www.scbt.com/scbt/product/pard6b-antibody-h-64)
PKCζ Santa	Cruz	Biotechnology sc-17781 G0212,	E2014 mouse	monoclonal	H-1 Recognises	human,	canine	and	rodent	aPKCζ Immunoblotting	of	total	cell	extracts	and	immunocytochemistry	of	human	tissue	sections	(https://www.scbt.com/scbt/product/pkc-zeta-antibody-h-1)	as	well	as	immunofluorescence	of	MDCK	cells	(JCB	204,	111-27,	2014)
Occludin Invitrogen/ThermoFisher	Scientific	 331500 1031831A mouse	monoclonal	OC-3F10 Recognises	human,	mouse	and	canine	occludin Immunoblotting	and	immunofluorescence	of	MDCK	and	Caco-2	cells	(https://www.thermofisher.com/antibody/product/Occludin-Antibody-clone-OC-3F10-Monoclonal/33-1500	and	BMC	Cell	Biol	10,	95,	2009)
Scribble Santa	Cruz	Biotechnology sc-11049 F0816 goat	polyclonal	C-20 Recognises	human	and	canine	Scribble Immunofluorescence	and	immunoblotting	in	human	and	canine	epithelial	cells	(https://www.scbt.com/scbt/product/scrib-antibody-c-20	and	(JCB	204,	111-27,	2014)
MRCKβ Santa	Cruz	Biotechnology sc-48834 J2909 rabbit	polyclonal	H-125 Recognises	human,	mouse	and	canine	MRCKβ Immunoblotting	and	immunofluorescence	of	MDCK	and	Caco-2	cells,	and	by	siRNA-mediated	depletion	(http://www.scbt.com/es/datasheet-48834-mrckbeta-h-125-antibody.html	and	this	manuscript)	
Ezrin	 Santa	Cruz	Biotechnology sc-58758 E0710 mouse	monoclonal	3C12 Recognises	human	and	canine	ezrin Immunoblotting	and	immunofluorescence,	and	by	siRNA-mediated	depletion	(https://www.scbt.com/scbt/product/ezrin-antibody-3c12	and	JCB	204,	111-27,	2014)
phospho-Ezrin	T567 abcam ab47293 803415 rabbit	polyclonal Recognises	ezrin	phosphorylated	at	Thr567	in	different	vertebrate	species Immunoblotting	cell	extracts	after	different	stimuli	promoting	phosphorylation	and	peptide	quenching	(http://www.abcam.com/ezrin-phospho-t567-antibody-ab47293.html#description_images_1	and	Nat	Comm	6,	8871,	2015)
phospho-MLC	S19 Cell	Signaling	Technology	 3675 3 mouse	monoclonal Recognises	MLC	phosphorylated	at	Ser19	in	different	species Immuoblotting	of	control	and	phosphase	treated	cell	extracts	and	by	immunofluorescence	(https://www.cellsignal.com/products/primary-antibodies/phospho-myosin-light-chain-2-ser19-mouse-mab/3675)
phospho(pp)MLC	T18,	S19	 Cell	Signaling	Technology	 3674 5 rabbit	polyclonal Recognises	MLC	phosphorylated	at	Thr18	and	Ser19	in	different	species Immuoblotting	control	and	stimulated	cell	extracts	and	by	immunofluorescence	staining	of	human	epithelial	cells	(https://www.cellsignal.com/products/primary-antibodies/phospho-myosin-light-chain-2-thr18-ser19-antibody/3674	and	Nat	Cell	Biol	13,	159-66,	2011)
phospho-MLC	S19 Cell	Signaling	Technology	 3971 3 rabbit	polyconal Recognises	MLC	phosphorylated	at	Ser19	in	different	species	including	 DrosophilaImmuoblotting	and	immunofluorescence	ionophore-stimulated	cells	(https://www.cellsignal.com/products/primary-antibodies/phospho-myosin-light-chain-2-ser19-antibody/3671	and	Develop	139,	3432-41,	2012)
SLK Santa	Cruz	Biotechnology sc-79068 B2410 goat	polyclonal	C-18 Recognises	human	and	canine	SLK Immunoblotting	and	immunofluorescence	of	human	and	canine	cells	(https://www.scbt.com/scbt/product/slk-antibody-c-18	and	this	manuscript)
NHERF1/EBP50 Santa	Cruz	Biotechnology sc-134485 H2313 rabbit	polyclonal	H-100 Recognises	NHERF1	of	various	vertebrate	species Immunoblotting	and	immunofluorescence	of	human	and	canine	cells	(https://webcache.googleusercontent.com/search?q=cache:Uc3dPrCjC8wJ:https://www.scbt.com/scbt/product/nherf-1-antibody-h-100+&cd=2&hl=en&ct=clnk&gl=uk&client=firefox-b	and	this	manuscript)
PKCζ Sigma	Aldrich	 SAB4502380 210805 rabbit	polyconal Recognises	PKCζ	in	multiple	species Immunoblotting	and	immunofluorescence	(http://www.sigmaaldrich.com/catalog/product/sigma/sab4502380?lang=en&region=GB)
p114RhoGEF GeneTex GTX629806 41449 mouse	monoclonal Recognises	mammalian	p114RhoGEF Immunoblotting	and	immunofluorescence,	and	siRNA-mediated	depletion	(http://www.genetex.com/ARHGEF18-antibody-GT1972-GTX629806.html	and	JCB	195,	245-61,	2011)
p114RhoGEF GeneTex GTX102223 39820 rabbit	polyconal Recognises	mammalian	p114RhoGEF Immunoblotting	and	immunofluorescence,	and	siRNA-mediated	depletion	(http://www.genetex.com/ARHGEF18-antibody-GTX102223.html	and	JCB	195,	245-61,	2011)
ZO-1 not	commercial not	applicable not	applicable rabbit	polyclonal Recognises	vertebrate	ZO-1	 Immunofluorescence	and	immunoblotting	combined	with	siRNA-mediated	depletion	(JCB	160,	729-40,	2003;	Mol	Cell	Biol	26,	2387-98)
Arm Developmental	Studies	Hybridoma	Bank N27-A1 not	applicable mouse	monoclonal	N27-A1 Recognises	 Drosophila	 Armadillo Immunofluorescence	and	immunoblotting	(http://dshb.biology.uiowa.edu/N2-7A1-ARMADILLO	and	Cell	63,	549-60,	1990)	
Gek not	commercial not	applicable not	applicable rabbit	polyclonal Recognises	 Drosophila	 GEK Immunofluorescence	of	wild	type	and	mutant	flies	(Develop	138,	4899-909,	2011)
phospho-Moesin	T558 not	commercial not	applicable not	applicable rabbit	polyclonal Recognises	 Drosophila	 Moesin	phosphorylated	at	Thr558 immunofluorescence	of	wild	type	and	mutant	flies	(Develop	131,	725-32,	2004)2	
 3	
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Supplementary Table 1: Details of antibodies used. Information about antibody sources 5	
and specificity. 6	
 7	
 8	
 9	
 10	
Supplementary Video 1: Induction of polarized myosin activation by Cdc42. Apical 11	
Cdc42 activation by conditional expression of Dbl3-myc in MDCK cells constitutively 12	
expressing EGFP-MLC was induced by adding tetracycline followed by recording image 13	
stacks every 5 minutes. Shown are projections of 4 images derived from the apical domain. 14	
The experiment was performed five times. 15	
 16	
